ABOUT
A scientist that gained ample experience in both immunology and Infectious Diseasein Clinical research during her PhD training at the Imperial College, UK, and during her research fellowship at the Infectious Disease Division of Massachusetts General Hospital, Harvard Medical School. She established and the director of “Immunocompromised Host Research”. Her research focuses on two different immunosuppressed populations of patients, namely HIV and organ recipient patients. She has founded the first HIV/AIDS laboratory within the Kingdom. Her research is not limited on basic sciences in infectious disease, but also on better management and designing strategies for preventing such infections. The vision of her research is improving the investigations in transplantation and reducing the chance of post-transplant complications and infections. In addition to excel in investigating research issues related to patient care and to fulfil the mission of the KFSHRC vision towards personalized Medicine in Infectious Disease. Dr. Al-Mozaini, is an Adviser to the National AIDS Program, World Health Organization (WHO) Regional Office of Eastern Mediterranean (EMRO). She is also an Adjunct Associate Professor faculty at the school of Applied Medical Laboratory Sciences, King Saud University, where she teaches Medical Virology course. She has been awarded with the L’OREAL-UNESCO for Women in Science Award in the MENA Region for 2015 and The Golden award for achievements in science, form the Arab Women Council, 2016. She is an activist for HIV/AIDS Awareness and Research and for Women empowerment in Research.
As part of this KSA Vision 2030 KFSH&RC is undergoing a large transformation to become a world leader in healthcare through excellence and innovation.
Our goal is to create a world-leading healthcare organization, one that offers high standards of safety and patient experience.